Related Experiment Video
Updated: Apr 17, 2026
06:08
Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
Published on: June 2, 2023
2.6K
Comparative effectiveness in thyroid cancer: key questions and how to answer them
1Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA, easare@mcw.edu.
Cancer Treatment and Research
|February 14, 2015
Summary
Comparative effectiveness studies are needed to resolve controversies in papillary thyroid cancer (PTC) treatment, including prophylactic central compartment neck dissection (pCCND) and radioactive iodine (RAI) therapy protocols.
Area of Science:
- Oncology
- Endocrinology
- Surgical Oncology
Background:
- Thyroid cancer treatment guidelines are debated despite extensive research.
- Key areas of controversy persist regarding optimal management strategies.
Purpose of the Study:
- To identify critical research gaps in thyroid cancer treatment.
- To advocate for robust comparative effectiveness studies to inform clinical practice.
Main Methods:
- The study reviews existing literature on thyroid cancer treatment controversies.
- It highlights the need for comparative studies on specific interventions.
Main Results:
- Significant controversies exist regarding prophylactic central compartment neck dissection (pCCND) in papillary thyroid cancer (PTC).
- Uncertainty remains regarding radioactive iodine (RAI) ablation therapy, including dosage and pre-therapy protocols (thyroid hormone withdrawal vs. recombinant thyroid stimulating hormone).
- The role of routine serum calcitonin measurement also requires further investigation.
Conclusions:
- High-quality comparative effectiveness research is essential to resolve current treatment controversies.
- Evidence-based recommendations for thyroid cancer management can be strengthened through targeted studies.
Related Concept Videos
01:21Cancer Survival Analysis
855
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
855
02:57Targeted Cancer Therapies
9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.2K
02:49Cancer Therapies
10.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.9K
01:27Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
01:09Bioequivalence of Drugs: Drugs with Multiple Indications
221
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
221